It is all about cuts in today's FTSE-100 news. For consumer staples giant Reckitt Benckiser (RB.) the most striking aspect of today's half-year update is the line 'Full year LFL net revenue target revised to +2-3% (from +3-4%) to reflect the slow start to the year'...
A month or so ago, I noted that Reckitt Benckiser (RB.) was a 'lower £60s buy in anticipation of a share price beginning with a '7' plus some solid dividend wrap-around...and a call option on that full split potential'. The rationale for this was not just the company's range of top products (Vanish, Nurofen, Dettol, Durex, etc.) nor even just potential upcoming split or a recently announced management evolution which I think is overdue. It was also centred on the likely resolution of the company's legacy problems with its ex pharmaceutical unit Indivior (INDV)...
Hello, Share Revellers. The mission of Slough-based giant Reckitt Benckiser (RB.) is to bring health and happiness into peoples’ home. This ‘consumer health and hygiene outfit’ does it in 60 countries across the globe. It’s bringing cheer into shareholder portfolios, too. While some Footsie members struggle, this jumbo continues to boost both revenue and profits...
Hello Share Tumblers. As someone who decries the continuing white male domination of Blighty's biggest firms, I'm rather sad to see that the big cheese at Reckitt Benckiser (RB.) is leaving. He's one of a very few top movers in the 100 companies of the Footsie who are not in the dominating WM category. In most of his 8 year tenure as chief executive, Rakesh Kapoor has done great things for the share price. However, in the last three years the shares have underperformed…
Hello Share Mashers. Reckitt Benckiser (RB.) is one of those Great British shares which sometimes misses the radar - but the cautious investor might be attracted. This company, which likes to call itself RB, is sometimes ignored by share critics. And yet it is doing rather well among its Footsie peers.
Search ShareProphets |
Recent Comments |